From Our Readers

From Our Readers

You Make the Call

Reader Responses: How does triple X syndrome interact with Fanconi anemia?

Here’s how readers responded to a You Make the Call question about allogeneic hematopoietic cell transplantation in a patient with Fanconi anemia. Disclaimer: ASH does...
You Make the Call

Reader Responses: Treating gout in a patient with G6PD deficiency

Here’s how readers responded to a You Make the Call question about treating gout in a patient with G6PD deficiency. Disclaimer: ASH does not recommend...

Off to the Races: The Breakthroughs of Immunotherapy

ASH Clinical News Associate Editor David Steensma, MD, reviews The Breakthrough, which traces the evolution of immunotherapy to treat – and potentially cure – cancer. Have you read any...
You Make the Call

Reader Responses: The genetic risk for familial CLL

Here’s how readers responded to a You Make the Call question about the genetic risk for familial chronic lymphocytic leukemia. Disclaimer: ASH does not recommend...

Perish to Publish: Repeated Episodes of Peer Rejection During the Publication Process

In adults – sensitive adults, in particular – who consider themselves academics, repeated episodes of peer rejection can have serious emotional repercussions. We (David...
You Make the Call

Reader Responses: Management of a patient with long-term B12 deficiency

Here’s how readers responded to a You Make the Call question about 42-year-old female patient who has had very low B12 levels for at...
You Make the Call

The significance of JAK2-positive test results in a healthy patient

Here’s how readers responded to a You Make the Call question about the significance of JAK2-positive test results in a healthy patient. Disclaimer: ASH does...
You Make the Call

Reader Responses: The significance of JAK2-positive test results in a healthy patient

Here’s how readers responded to a You Make the Call question about the significance of JAK2-positive test results in a healthy patient. Disclaimer: ASH does not...

An ASH Annual Meeting Post-Vivum

“So, what did you learn from ASH?” asked my advisor a couple of weeks after I returned from my first American Society of Hematology...
You Make the Call

Best options for an older patient with Ph+ B-cell ALL

Here’s how readers responded to a You Make the Call question about best options for an older patient with Philadelphia chromosome (Ph)–positive B-cell acute...
Advertisement

Current Issue

July 2019 Bonus Mid-Year Edition, Volume 5, Issue 9

This issue features a look at research espionage, coverage from the ASCO and EHA annual meetings, and more.